Antibody modeling assessment II. Structures and models

Proteins: Structure, Function and Bioinformatics

Volumn 82, Issue 8, 2014, Pages 1563-1582

  Teplyakov, Alexey ^a   Luo, Jinquan ^a   Obmolova, Galina ^a   Malia, Thomas J ^a   Sweet, Raymond ^a   Stanfield, Robyn L ^b   Kodangattil, Sreekumar ^c   Almagro, Juan Carlos ^c   Gilliland, Gary L ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c PFIZER INC   (United States)

Author keywords

Canonical structure; CDR; Crystal structure; Structure prediction; VL VH packing

Indexed keywords

AMINO ACID SEQUENCE; ANTIBODY STRUCTURE; ARTICLE; CRYSTAL STRUCTURE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN DATABASE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; ISOMERISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

COMPLEMENTARITY DETERMINING REGION; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN VARIABLE REGION;

AMINO ACID SEQUENCE; ANIMALS; COMPLEMENTARITY DETERMINING REGIONS; CRYSTALLOGRAPHY, X-RAY; DATABASES, PROTEIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; ISOMERISM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION;

EID: 84904515208     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24554     Document Type: Article

References (50)

1. Sircar A. Methods for the homology modeling of antibody variable regions. Methods Mol Biol 2012;857:301-311.
2. Ramos OH. Computer-assisted modeling of antibody variable domains. Methods Mol Biol 2012;907:39-55.
3. Kuroda D, Shirai H, Jacobson MP, Nakamura H. Computer-aided antibody design. Protein Eng Des Sel 2012;25:507-521.
4. Al-Lazikani B, Jung J, Xiang Z, Honig B. Protein structure prediction. Curr Opin Chem Biol 2001;5:51-56.
5. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000;28:235-242.
6. Chothia C, Lesk A. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987;196:901-917.
7. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. Antibody structure, prediction and redesign. Biophys Chem 1997;68:9-16.
8. Abhinandan KR, Martin AC. Analysis and prediction of VH/VL packing in antibodies. Protein Eng Des Sel 2010;23:689-697.
9. Davies DR, Metzger H. Structural basis of antibody function. Annu Rev Immunol 1983;1:87-117.
10. Kabat EA. The structural basis of antibody complementarity. Adv Protein Chem 1978;32:1-75.
11. Morea V, Lesk AM, Tramontano A. Antibody modeling: implications for engineering and design. Methods 2000;20:267-279.
12. Reczko M, Martin AC, Bohr H, Suhai S. Prediction of hypervariable CDR-H3 loop structures in antibodies. Protein Eng 1995;8:389-395.
13. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol 1998;275:269-294.
14. Shirai H, Kidera A, Nakamura H. Structural classification of CDR-H3 in antibodies. FEBS Lett 1996;399:1-8.
15. Oliva B, Bates PA, Querol E, Avilés FX, Sternberg MJ. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. J Mol Biol 1998;279:1193-1210.
16. Kuroda D, Shirai H, Kobori M, Nakamura H. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Proteins 2008;73:608-620.
17. Sircar A, Kim ET, Gray JJ. RosettaAntibody: antibody variable region homology modeling server. Nucleic Acids Res 2009;37:W474-W479.
18. Choi Y, Deane CM. Predicting antibody complementarity determining region structures without classification. Mol Biosyst 2011;7:3327-3334.
19. Zhu K, Day T. Ab initio structure prediction of the antibody hypervariable H3 loop. Proteins 2013;81:1081-1089.
20. Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics 2008;24:1953-1954.
21. North B, Lehmann A, Dunbrack RL. A new clustering of antibody CDR loop conformations. J Mol Biol 2011;406:228-256.
22. Abhinandan KR, Martin AC. 2008. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol Immunol 2008;45:3832-3839.
23. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989;342:877-883.
24. Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr 2010;D66:12-21.
25. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr 2010;D66:213-221.
26. Kabsch W. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr 1976;A32:922-923.
27. de Wildt RM, Hoet RM, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 1999;285:895-901.
28. Jayaram N, Bhowmick P, Martin AC. Germline VH/VL pairing in antibodies. Protein Eng Des Sel 2012;25:523-529.
29. Dunbar J, Fuchs A, Shi J, Deane CM. ABangle: characterising the VH-VL orientation in antibodies. Protein Eng Des Sel 2013;26:611-620.
30. Almagro JC, Beavers MP, Hernandez-Guzman F, Maier J, Shaulsky J, Butenhof K, Labute P, Thorsteinson N, Kelly K, Teplyakov A, Luo J, Sweet R, Gilliland GL. Antibody modeling assessment. Proteins 2011;79:3050-3066.
31. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, Dugger D, Gordon N, Sidhu SS, Fellouse FA, Komuves L, French DM, Ferrando RE, Lam C, Compaan D, Yu C, Bosanac I, Hymowitz SG, Kelley RF, Dixit VM. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008;134:668-678.
32. Maun HR, Wen X, Lingel A, de Sauvage FJ, Lazarus RA, Scales SJ, Hymowitz SG. Hedgehog pathway antagonist 5E1 binds hedgehog at the pseudo-active site. J Biol Chem 2010;285:26570-26580.
33. Zhao Z, Worthylake D, LeCour L Jr, Maresh GA, Pincus SH. Crystal structure and computational modeling of the fab fragment from a protective anti-ricin monoclonal antibody. PLoS One 2012;7:e52613.
34. Ni YG, Di Marco S, Condra JH, Peterson LB, Wang W, Wang F, Pandit S, Hammond HA, Rosa R, Cummings RT, Wood DD, Liu X, Bottomley MJ, Shen X, Cubbon RM, Wang SP, Johns DG, Volpari C, Hamuro L, Chin J, Huang L, Zhao JZ, Vitelli S, Haytko P, Wisniewski D, Mitnaul LJ, Sparrow CP, Hubbard B, Carfí A, Sitlani A. A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo. J Lipid Res 2011;52:78-86.
35. Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 2009;4:1-13.
36. Narayanan A, Sellers BD, Jacobson MP. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. J Mol Biol 2009;388:941-953.
37. Freeman MM, Seaman MS, Rits-Volloch S, Hong X, Kao CY, Ho DD, Chen B. Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody. Structure 2010;18:1632-1641.
38. Mahalingam B, Ajroud K, Alonso JL, Anand S, Adair BD, Horenstein AL, Malavasi F, Xiong JP, Arnaout MA. Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug design. J Immunol 2011;187:6393-6401.
39. Stanfield R, Cabezas E, Satterthwait A, Stura E, Profy A, Wilson I. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. Structure 1999;7:131-142.
40. Larsen NA, Zhou B, Heine A, Wirsching P, Janda KD, Wilson IA. Crystal structure of a cocaine-binding antibody. J Mol Biol 2001;311:9-15.
41. Sawicki MW, Ng PC, Burkhart BM, Pletnev VZ, Higashiyama T, Osawa Y, Ghosh D. Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody-antigen interactions. Mol Immunol 1999;36:423-432.
42. Tramontano A, Chothia C, Lesk AM. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. J Mol Biol 1990;215:175-182.
43. Brightbill HD, Jeet S, Lin Z, Yan D, Zhou M, Tan M, Nguyen A, Yeh S, Delarosa D, Leong SR, Wong T, Chen Y, Ultsch M, Luis E, Ramani SR, Jackman J, Gonzalez L, Dennis MS, Chuntharapai A, DeForge L, Meng YG, Xu M, Eigenbrot C, Lee WP, Refino CJ, Balazs M, Wu LC. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. J Clin Invest 2010;120:2218-2229.
44. Chen X, Kim TD, Carman CV, Mi LZ, Song G, Springer TA. Structural plasticity in Ig superfamily domain 4 of ICAM-1 mediates cell surface dimerization. Proc Natl Acad Sci USA 2007;104:15358-15363.
45. Tormo J, Blaas D, Parry NR, Rowlands D, Stuart D, Fita I. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBO J 1994;13:2247-2256.
46. Luftig MA, Mattu M, Di Giovine P, Geleziunas R, Hrin R, Barbato G, Bianchi E, Miller MD, Pessi A, Carfí A. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nat Struct Mol Biol 2006;13:740-747.
47. Obmolova G, Teplyakov A, Malia TJ, Grygiel TL, Sweet R, Snyder LA, Gilliland GL. Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888. Mol Immunol 2012;51:227-233.
48. Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009;74:497-514.
49. Stanfield RL, Zemla A, Wilson IA, Rupp B. Antibody elbow angles are influenced by their light chain class. J Mol Biol 2006;357:1566-1574.
50. Yin J, Andryski SE, Beuscher AE 4th, Stevens RC, Schultz PG. Structural evidence for substrate strain in antibody catalysis. Proc Natl Acad Sci USA 2003;100:856-861.